Navigation Links
The challenge of financing today's Midwest life science companies

In our world of Midwest life sciences, one of the most difficult issues has been achieving funding to successfully propel companies along a pathway to commercial launch of products and some kind of positive cash flow.

There are now 48 Midwest VC groups in 16 states with combined capital of $2 billion under management that are affiliated with the ever-......

Full article >>> al syndication takes place. Deal syndication means that theres usually at least one or two lead funds on a deal that help bring in two or more VCs. A recent example of Midwest deal syndication is the successful financing round of Missouri-based biotech company Kereos, which raised $20 million.

So where does that leave an early stage company? There a couple avenues aside from seeking V......

Full article >>> n some creative efforts undertaken in this area in a number of states (particularly in Illinois, Michigan and Wisconsin). The problem is that most of these efforts are limited to $200,000 or less. While TIF financing can be higher than this amount, it usually involves some kind of multimillion-dollar construction effort and is usually city-centric.

Another source of biotech funding: Pa......

Full article >>> I>net present value (NPV) calculation of the profit streams to look at how much money is going to the innovator company and the partner company. The earlier the stage of development of the companys product, the lesser share the innovator company will pick up.

The closer the product is to the market, the more the innovator companys share of NPV profits increases. By Michael Rosen 10/17/05

Related biology technology :

1. WARF questions relevancy of documents used to uphold patent challenge
2. Wisconsin biosciences rise to the challenge
3. Heres why Wisconsins stem cell patents are being challenged
4. Patent office upholds challenge to WARF stem cell patents
5. WARF challenges show need for patent reform
6. Manufacturers face challenges of innovation
7. WARF says its ready for a legal challenge on stem cells
8. Wisconsin Rapids firm will challenge student security skills
9. Consumer, business technologies face same challenges
10. RFID medical devices - Opportunities and challenges
11. Oshkoshs robotic truck qualifies for DARPA challenge
Post Your Comments:

(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc ... announced today that it has closed the sale of ... to Guerbet (GBT- NYSE Euronext) in a transaction valued ... four manufacturing facilities and a total of approximately 1,000 ... the St. Louis area. This ...
(Date:11/26/2015)... 26, 2015 ... Accutest Research Laboratories, a leading independent ... (CRO), has formed a strategic partnership ... Temple Health for joint work on ... ) , --> ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
Breaking Biology Technology:
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
Breaking Biology News(10 mins):